NO20000062D0 - Prostaglandinderivater fri for bieffekter for behandlingen av glaukom - Google Patents

Prostaglandinderivater fri for bieffekter for behandlingen av glaukom

Info

Publication number
NO20000062D0
NO20000062D0 NO20000062A NO20000062A NO20000062D0 NO 20000062 D0 NO20000062 D0 NO 20000062D0 NO 20000062 A NO20000062 A NO 20000062A NO 20000062 A NO20000062 A NO 20000062A NO 20000062 D0 NO20000062 D0 NO 20000062D0
Authority
NO
Norway
Prior art keywords
glaucoma
treatment
side effects
prostaglandin derivatives
derivatives free
Prior art date
Application number
NO20000062A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000062L (no
Inventor
Johan W Stjernschantz
Bahram Resul
Staffan Lake
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000062(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000062L publication Critical patent/NO20000062L/no
Publication of NO20000062D0 publication Critical patent/NO20000062D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20000062A 1997-07-11 2000-01-06 Prostaglandinderivater fri for bieffekter for behandlingen av glaukom NO20000062D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (sv) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
PCT/SE1998/001368 WO1999002165A1 (en) 1997-07-11 1998-07-10 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (2)

Publication Number Publication Date
NO20000062L NO20000062L (no) 2000-01-06
NO20000062D0 true NO20000062D0 (no) 2000-01-06

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000062A NO20000062D0 (no) 1997-07-11 2000-01-06 Prostaglandinderivater fri for bieffekter for behandlingen av glaukom

Country Status (19)

Country Link
EP (1) EP1014991A1 (is)
JP (1) JP2002509543A (is)
KR (1) KR20010021682A (is)
CN (1) CN1169528C (is)
AU (1) AU739828B2 (is)
BR (1) BR9815501A (is)
CA (1) CA2294779A1 (is)
HK (1) HK1029942A1 (is)
HU (1) HUP0003106A3 (is)
IL (1) IL133871A (is)
IS (1) IS5333A (is)
NO (1) NO20000062D0 (is)
NZ (1) NZ501834A (is)
PL (1) PL337940A1 (is)
RU (1) RU2207858C2 (is)
SE (1) SE9702706D0 (is)
SK (1) SK183499A3 (is)
TR (1) TR200000008T2 (is)
WO (1) WO1999002165A1 (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
AU2003299137A1 (en) * 2002-09-16 2004-04-23 Texas Tech University System Inhibition of metallo-beta-lactamase
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
JPWO2009133863A1 (ja) 2008-04-28 2011-09-01 国立大学法人浜松医科大学 Ｅｐ１アゴニストを含有してなる免疫増強剤
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (en) 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
AU2009354014B2 (en) * 2009-10-16 2014-08-28 Cayman Chemical Company, Incorporated Process for the preparation of F-series prostaglandins
KR102070567B1 (ko) 2012-03-28 2020-01-29 메르크 파텐트 게엠베하 바이시클릭 피라지논 유도체
JP2012246301A (ja) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Ｆ系プロスタグランジン類を調製する方法
ES2852377T3 (es) 2013-03-15 2021-09-13 Aerie Pharmaceuticals Inc Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
CN110506037A (zh) 2017-03-31 2019-11-26 爱瑞制药公司 芳基环丙基-氨基-异喹啉酰胺化合物
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
WO1994008585A1 (en) * 1992-10-13 1994-04-28 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma

Also Published As

Publication number Publication date
JP2002509543A (ja) 2002-03-26
AU739828B2 (en) 2001-10-18
NO20000062L (no) 2000-01-06
TR200000008T2 (tr) 2000-05-22
WO1999002165A1 (en) 1999-01-21
BR9815501A (pt) 2001-07-17
RU2207858C2 (ru) 2003-07-10
SE9702706D0 (sv) 1997-07-11
EP1014991A1 (en) 2000-07-05
PL337940A1 (en) 2000-09-11
IL133871A0 (en) 2001-04-30
IL133871A (en) 2004-09-27
KR20010021682A (ko) 2001-03-15
HUP0003106A3 (en) 2002-12-28
CN1169528C (zh) 2004-10-06
CA2294779A1 (en) 1999-01-21
IS5333A (is) 2000-01-07
AU8368398A (en) 1999-02-08
CN1262623A (zh) 2000-08-09
SK183499A3 (en) 2000-07-11
HK1029942A1 (en) 2001-04-20
HUP0003106A2 (hu) 2001-01-29
NZ501834A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
NO20000062D0 (no) Prostaglandinderivater fri for bieffekter for behandlingen av glaukom
EE04190B1 (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks
DE69613368T2 (de) Chinazolin derivate
DE69613369T2 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20001962D0 (no) Terapeutisk anvendelse av kinolinderivater
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
NO910395L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO912797L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO905327L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO993948D0 (no) Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser
SE9403186D0 (sv) Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
FI951047A0 (fi) Menetelmä indolijohdannaisten valmistamiseksi
NO934692D0 (no) Asymmetrisk hydrogenering av dihydrofuro-imidasolderivater
EE200300194A (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks
NO974458D0 (no) Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater